Plasma proteins are a diverse collection of molecules dissolved in the liquid portion of your blood, and they do far more than float passively through your veins. They maintain fluid balance, fight infections, ferry hormones and drugs to where they’re needed, and form clots to stop bleeding. Their concentrations in your blood can reveal liver damage, kidney disease, immune deficiencies, and even certain cancers. The most abundant 22 proteins account for roughly 99% of total plasma protein by weight, yet the full roster numbers in the thousands, with concentrations spanning more than 12 orders of magnitude from the most to least abundant.
Albumin, the Workhorse
Albumin makes up about half of all plasma protein by weight, and it pulls double duty. Its first job is maintaining what’s called oncotic pressure: because albumin molecules are too large to slip easily through capillary walls, they create an osmotic pull that draws water from the tissues back into the bloodstream. Without enough albumin, fluid leaks into surrounding tissue and causes swelling, which is one reason people with severe liver or kidney disease develop puffy ankles or a swollen abdomen.1PubMed. Physiology, Colloid Osmotic Pressure
Albumin’s second major role is as a transport and reservoir protein. It binds a huge variety of substances, including fatty acids, thyroid hormones, bilirubin, calcium, and many medications. That binding capacity means albumin influences how quickly a drug reaches its target and how long it stays active in the body.2PubMed. Serum albumin: clinical significance of drug binding and development as drug delivery vehicle Human serum albumin also interacts with cellular receptors, which researchers have begun exploiting to design albumin-based drug delivery systems.3PubMed Central. Review: modifications of human serum albumin and their binding effect
Because albumin is so central to fluid balance and drug transport, clinicians pay close attention to serum albumin levels. A sharp drop after surgery, for example, can lower oncotic pressure enough to cause clinical problems, which is why some surgical teams give albumin infusions during the procedure to counteract the decline.4PubMed. Colloid osmotic pressure and serum albumin following surgery
The Globulin Families
When blood is run through a standard laboratory technique called serum protein electrophoresis, the proteins separate into bands based on size and charge. Albumin forms one tall peak. The remaining proteins form several smaller peaks collectively called globulins, typically grouped into alpha-1, alpha-2, beta, and gamma fractions. Each fraction contains proteins with distinct jobs.
Alpha Globulins
The alpha-1 fraction includes alpha-1 antitrypsin (AAT), a protein best known for neutralizing destructive enzymes released by white blood cells during inflammation. When neutrophils swarm to a site of infection, they release proteases that can damage nearby healthy tissue, especially in the lungs. AAT acts as a molecular trap: it presents a reactive loop to those proteases, gets cleaved, then locks onto the enzyme and changes shape so that the whole complex can be cleared from the blood.5PubMed Central. A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application Beyond protease control, AAT has turned out to be a surprisingly versatile molecule with anti-inflammatory, immune-modulating, and even antimicrobial properties.6PubMed. Role of alpha-1 antitrypsin in human health and disease People born with a genetic deficiency in AAT face a heightened risk of lung disease and liver damage, because those tissues bear the brunt of unchecked protease activity and misfolded AAT protein accumulation.
The alpha-2 fraction contains proteins like alpha-2-macroglobulin, another protease trapper, and haptoglobin, which binds free hemoglobin released when red blood cells break apart. That binding prevents the loose hemoglobin from causing oxidative damage to blood vessels and kidneys.7PubMed. alpha2-Macroglobulin and haptoglobin suppress amyloid formation by interacting with prefibrillar protein species Interestingly, both alpha-2-macroglobulin and haptoglobin also appear to interfere with amyloid formation, the clumping of misfolded proteins implicated in diseases like Alzheimer’s.
Beta Globulins
The beta fraction is home to transferrin, the protein responsible for shuttling iron through the bloodstream. Iron is essential for making hemoglobin and fueling cellular energy production, but free iron is toxic, so the body handles it with extreme care. Transferrin picks up iron absorbed from the gut or recycled from old red blood cells and delivers it to bone marrow, the liver, and other tissues that need it. The whole system is coordinated by hepcidin, a hormone from the liver that acts as a master switch for iron absorption and release.8PubMed Central. Iron transport proteins: Gateways of cellular and systemic iron homeostasis Beta globulins also include complement proteins, part of the immune system’s first line of defense that can punch holes in bacterial membranes, and lipoproteins that carry cholesterol and triglycerides.
Gamma Globulins (Immunoglobulins)
The gamma fraction consists almost entirely of immunoglobulins, better known as antibodies. These are the heavy hitters of adaptive immunity. Each immunoglobulin molecule is built from two heavy protein chains and two light chains, with one end specialized for latching onto a specific invader and the other end designed to recruit immune cells or activate complement to destroy the target.9PubMed Central. Structure and function of immunoglobulins
There are five main classes. IgG is the most abundant in blood and provides long-term memory against past infections. IgA dominates in mucous membranes and secretions like saliva and breast milk. IgM is the first antibody produced during a new infection. IgE drives allergic reactions and parasite defense. IgD’s exact role is still somewhat murky, but it appears on the surface of immature immune cells. IgG itself splits into four subclasses, each with slightly different properties for activating complement or binding to immune cell receptors.9PubMed Central. Structure and function of immunoglobulins This diversity matters clinically: certain immune deficiencies affect only one subclass, so a person’s total IgG level can look normal while a specific subclass is dangerously low.
Clotting Factors and Fibrinogen
A separate and crucial group of plasma proteins manages blood clotting. When a blood vessel is damaged, a cascade of clotting factors activates in sequence, each one switching on the next, until the enzyme thrombin converts the soluble protein fibrinogen into insoluble fibrin strands that mesh together to form a stable clot. The system is tightly balanced: pro-clotting pathways work alongside natural inhibitors that confine the clot to the injury site and prevent it from spreading throughout the bloodstream.10PubMed Central. Overview of the coagulation system
Thrombin doesn’t just convert fibrinogen. It simultaneously activates Factor XIII, a “cross-linking” factor that welds the fibrin strands together so the clot is strong enough to resist being washed away by blood flow. Research using radiolabeled proteins has shown that fibrinogen and Factor XIII are cleaved by thrombin at roughly the same pace during clotting, with visible gelation occurring once about a quarter of the available fibrinogen has been converted.11PubMed Central. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting That coordination matters: if Factor XIII is missing or deficient, clots are fragile and patients bleed excessively even though their fibrin formation looks normal at first glance.
Acute-Phase Proteins and Inflammation
When the body faces infection, trauma, or severe inflammation, the liver ramps up production of a group of plasma proteins called positive acute-phase proteins. These include C-reactive protein (CRP), serum amyloid A, fibrinogen, and haptoglobin, among others. Their functions range from trapping microorganisms and activating complement to scavenging free hemoglobin and neutralizing damaging enzymes.12PubMed Central. Acute-phase proteins: As diagnostic tool At the same time, the liver dials back production of certain other proteins, like albumin and transferrin, which is why albumin levels often drop during serious illness even when the liver itself is healthy.
The signal for this shift comes from inflammatory cytokines released by immune cells at the site of injury. CRP, in particular, can rise a hundredfold within a day or two of a major insult, making it a widely used clinical marker. When your doctor orders a CRP test to check for infection or monitor an autoimmune flare, they’re taking advantage of the acute-phase response. Because acute-phase protein changes are not specific to any one disease, however, they serve as flags that something is wrong rather than as precise diagnostic tools on their own.
What Protein Electrophoresis Can Reveal
Serum protein electrophoresis (SPEP) is one of the most informative single tests a lab can run. By separating plasma proteins into their characteristic bands, it can highlight abnormalities that point toward specific diseases. A low albumin peak, for instance, can signal liver failure, malnutrition, or kidney losses. A blunted gamma region can indicate an immune deficiency.
The finding that draws the most clinical attention is a monoclonal spike, a sharp, narrow peak in the gamma region caused by a single clone of immune cells churning out one type of immunoglobulin. A monoclonal spike is the hallmark of plasma cell disorders. In otherwise healthy people, it usually indicates monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma, both premalignant conditions that carry a lifelong risk of progressing to full-blown multiple myeloma or a related cancer.13PubMed Central. Does my patient with a serum monoclonal spike have multiple myeloma? Distinguishing MGUS from myeloma is critical because the management and prognosis differ enormously.14PubMed Central. The role of serum protein electrophoresis in the detection of multiple myeloma: an experience of a corporate hospital
Patients who have been treated for myeloma sometimes develop a different electrophoresis pattern: multiple small bands called an oligoclonal pattern, which reflects immune recovery and the emergence of new, non-cancerous antibody-producing cells. While this is generally a good sign, it can complicate follow-up lab work. In particular, the presence of oligoclonal bands can skew the results of free light chain assays used to monitor residual disease.15PubMed Central. Oligoclonal Pattern/Abnormal Protein Bands in Post-Treatment Plasma Cell Myeloma Patients: Implications for Protein Electrophoresis and Serum Free Light Chain Assay Results
The Liver as the Protein Factory
The liver manufactures the vast majority of circulating plasma proteins, including albumin, fibrinogen, most clotting factors, and many acute-phase proteins.16PubMed Central. Structural changes of proteins in liver cirrhosis and consequential changes in their function When the liver is damaged by chronic disease, this production falters. In cirrhosis, albumin synthesis drops in step with the severity of liver damage: the worse the liver function, the less albumin the body can make. Even patients with compensated cirrhosis, where the liver is still managing most of its duties, show impaired albumin production after meals.17PubMed. Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils
Fibrinogen production also declines in advanced liver disease, though in a slightly different pattern. Research measuring actual synthesis rates in patients with advanced chronic liver failure found that albumin synthesis was low and tracked closely with liver-function scores, while fibrinogen synthesis was often still in the normal range, apparently sustained by chronic inflammation that stimulates its production even as the liver’s general capacity drops.18PubMed. Albumin and fibrinogen synthesis rates in advanced chronic liver disease That disconnect explains a clinical puzzle: some cirrhotic patients have profoundly low albumin yet surprisingly adequate clotting, at least until the disease progresses further.
Cirrhosis also changes the proteins that the liver does manage to produce. Chemical modifications like oxidation and abnormal sugar attachments accumulate on these proteins, altering their shape and reducing their function.16PubMed Central. Structural changes of proteins in liver cirrhosis and consequential changes in their function A patient might have a measured albumin level that looks only modestly low, yet the albumin that is present may not bind drugs or maintain oncotic pressure as effectively as it should.
What Happens When the Kidneys Leak
If the liver is the main producer, the kidneys are the main gatekeepers. Healthy kidneys filter enormous volumes of blood but retain plasma proteins by blocking anything above a certain size and charge at the glomerular barrier. When that barrier is damaged, as in nephrotic syndrome, proteins pour into the urine. Albumin, being relatively small among plasma proteins, is the first to go, but it is far from alone: binding proteins for hormones, vitamins, and ions, plus immunoglobulins and clotting factors, all get lost.19PubMed Central. Nephrotic Syndrome Complications – New and Old. Part 1
The liver tries to compensate by increasing protein production across the board, but it does so indiscriminately. It cannot selectively replace just the missing proteins. The result is a distorted plasma protein profile: levels of some protective proteins remain low because the liver cannot keep up with their urinary losses, while others, particularly larger proteins like certain lipoproteins and clotting factors, accumulate because they are overproduced but not efficiently excreted. This imbalance drives many of the complications of nephrotic syndrome. The fall in oncotic pressure causes edema. The loss of IgG weakens immunity. The loss of erythropoietin can lead to anemia. And the overproduction of clotting factors, combined with the loss of natural anticoagulants, increases the risk of blood clots.20PubMed. Nonrenal complications of the nephrotic syndrome
Plasma Proteins as Therapies
Because plasma proteins play such specific and essential roles, purified versions of them have become important treatments. Intravenous immunoglobulin (IVIg), made from pooled donor plasma, is used both as replacement therapy for people who can’t produce enough antibodies and as an immune-modulating treatment for autoimmune diseases. Therapeutic plasma exchange (TPE) takes a different approach: it removes the patient’s plasma entirely and replaces it with donor plasma, albumin, or another fluid. This physically strips out harmful antibodies, immune complexes, or toxic proteins, and it can also deliver deficient plasma components at the same time. TPE is used for conditions ranging from thrombotic thrombocytopenic purpura to myasthenia gravis to acute liver failure.21PubMed. Thawed plasma (TP) as a substitute for intravenous immune globulin (IVIG) to prevent hypogammaglobulinemia post-therapeutic plasma exchange
A practical complication of repeated plasma exchange is that it strips out the patient’s own immunoglobulins along with the harmful ones, causing secondary hypogammaglobulinemia. IVIg infusions after the procedure can restore IgG levels, but not every patient tolerates IVIg well. In those cases, thawed donor plasma has been explored as an alternative replacement fluid that provides some immunoglobulin alongside the other plasma proteins.21PubMed. Thawed plasma (TP) as a substitute for intravenous immune globulin (IVIG) to prevent hypogammaglobulinemia post-therapeutic plasma exchange
How the Plasma Proteome Changes With Age
Your plasma protein profile is not static over a lifetime. A study that measured nearly 3,000 plasma proteins in over 4,000 people aged 18 to 95 found that the proteome does not change at a steady, gradual rate. Instead, it shifts in waves, with pronounced transitions around the fourth, seventh, and eighth decades of life. Each wave reflected different biological pathways and correlated with distinct age-related diseases and traits.22PubMed Central. Undulating changes in human plasma proteome profiles across the lifespan The implication is that aging is not a smooth decline at the molecular level; it happens in bursts, and those bursts may open windows where specific disease risks spike.
Even earlier in life, the proteome undergoes dramatic remodeling. Research comparing the plasma of newborns, children at various ages, and adults found that roughly 10% of detectable protein spots showed significant differences in abundance across those age groups.23PLoS ONE. Age-Related Differences in Plasma Proteins: How Plasma Proteins Change from Neonates to Adults A newborn’s plasma looks strikingly different from a child’s, which in turn looks different from an adult’s. These shifts are driven by the maturation of the immune system, changes in liver function, and the changing metabolic demands of growth. Pediatric reference ranges for plasma proteins differ from adult ones for good reason, and applying adult cutoffs to a child’s lab work can produce misleading results.
When Sugar Damages the Machinery
Diabetes offers a vivid example of how disease can alter plasma proteins at the molecular level. When blood sugar remains chronically elevated, glucose reacts with proteins through a non-enzymatic process called glycation. This is the same basic chemistry behind the HbA1c test, which measures glycated hemoglobin. But hemoglobin is not the only target. Albumin, transferrin, fibrinogen, and many other plasma proteins undergo glycation as well.24PubMed Central. Prevention of non-enzymatic glycosylation (glycation): Implication in the treatment of diabetic complication
Over time, glycated proteins form advanced glycation end products, or AGEs, which cross-link with other proteins and disrupt their normal structure. Glycated transferrin, for instance, has impaired iron-binding ability, which can contribute to the iron metabolism abnormalities seen in some people with diabetes. The accumulated AGEs reduce enzyme activity, alter how long proteins survive in circulation, and change the way the immune system recognizes them.25Diabetes, Metabolic Syndrome and Obesity. Non-Enzymatic Glycation of Transferrin and Diabetes Mellitus This broad molecular damage to the plasma proteome helps explain why long-standing, poorly controlled diabetes causes such a wide array of complications, from vascular disease to impaired wound healing to increased susceptibility to infection.
The Challenge of Measuring the Full Proteome
One reason plasma proteins remain an active frontier of research is that they are remarkably difficult to measure comprehensively. The concentration range spans more than 12 orders of magnitude: albumin is present in grams per liter, while some signaling molecules exist at picograms per liter. Albumin alone accounts for about half of total protein by weight, and the top 22 proteins make up around 99%.26PubMed Central. Mass Spectrometry-Based Plasma Proteomics: Considerations from Sample Collection to Achieving Translational Data Trying to detect low-abundance proteins in that environment is like trying to hear a whisper at a rock concert.
Traditional approaches strip out the high-abundance proteins first, which improves sensitivity for rare molecules but adds processing steps, cost, and the risk of accidentally removing proteins of interest that are bound to albumin. Newer automated workflows are pushing the boundaries of how many proteins can be reliably detected and quantified in a single blood draw. Recent comparisons of profiling methods have found that some newer platforms outperform conventional workflows in terms of the number of proteins detected, the accuracy of quantification, and reproducibility across large numbers of samples.27PubMed Central. Frontiers in plasma proteome profiling platforms: innovations and applications The practical goal driving all of this work is biomarker discovery: finding low-abundance proteins that signal a disease years before symptoms appear, ideally from a routine blood test.